IINN

Inspira Technologies Oxy B.H.N. Ltd.

1.07 USD

Last updated Dec 10, 05:50 UTC

Yesterday HIGH

$1.03

Yesterday LOW

$0.99

52w HIGH

$1.99

52w LOW

$0.98

EPS

1

PE

1.07

Next Earnings

Dec 22, 2023

Overview News Government Trades

Inspira Technologies Oxy B.H.N. Ltd. stock is down -12.3% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 December’s closed higher than November.

Inspira Technologies Oxy B.H.N. Ltd. engages in the research, development, manufacture, and marketing of respiratory support technology. Its lead product is the augmented respiration technology system (ART) The company was formerly known as Insense Medical Ltd.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

-

Website

inspira-technologies.com

Benzinga Newsdesk

Tue Dec 27, 2022

Inspira Technologies Signs Strategic OEM Agreement With Terumo Cardiovascular

Terumo Cardiovascular is a division of Terumo Corporation, a leading medical device company operating in 160+ countries and regions RA'ANANA, Israel, Dec. 27, 2022 /PRNewswire/ -- Inspira
Benzinga Insights

Tue Dec 20, 2022

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 298 companies achieved new lows for the year.
Benzinga Newsdesk

Tue Dec 20, 2022

Inspira Technologies Begins Manufacturing Of The Alice CPB Device, Ahead Of Planned 2023 FDA Submission

nspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced
Benzinga Insights

Wed Dec 14, 2022

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 115 stocks hit new 52-week lows.
Benzinga Newsdesk

Wed Dec 14, 2022

Inspira Technologies Oxy B.H.N Signs Agreement To Conduct Clinical Study Of HYLA Blood Sensor; Signed Agreement To Conduct Study With Sheba Medical Center In Israel, Study Expected To Commence In The Q1 2023

Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLATM Blood Sensor The agreement with Sheba Medical Center, 10th ranked hospital in the world*, to be the first site for the HYLA
Benzinga Newsdesk

Wed Nov 23, 2022

Inspira Reports Cash, Cash Equivalents As Of Sept. 30, 2022 Of $16.2M
Benzinga Newsdesk

Tue Nov 22, 2022

Inspira Technologies Signs Exclusive Distribution Agreement For HYLA Blood Sensors With Innovimed

The agreement signed with Innovimed is over a 5-year period, subject to regulatory approvals RA'ANANA, Israel, Nov. 22, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.
Benzinga Newsdesk

Thu Nov 10, 2022

Inspira Technologies Granted Patent By The Israeli Patent Office For Key Safety Component For The INSPIRATM ART System

Inspira™ Technologies OXY B.H.N.
Lisa Levin

Mon Oct 3, 2022

Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket

Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.
Benzinga Newsdesk

Wed Sep 7, 2022

Inspiratm Technologies Performed Hylatm Blood Sensor In-Vivo Study, In Preparation Of Planned Human Studies

- Reuters